Trimetazidine ameliorates hindlimb ischaemic damage in type 2 diabetic mice

BACKGROUND: Ischaemia caused by lower extremity artery stenosis is the main cause of peripheral artery disease (PAD) in patients with diabetes. Trimetazidine (TMZ) has traditionally been used as an anti-ischaemic drug for coronary artery disease. The effect of TMZ on PAD in a diabetic animal model a...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yan, Xu, Qinqin, Li, Tao, Shao, Shiying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281072/
https://www.ncbi.nlm.nih.gov/pubmed/34259103
http://dx.doi.org/10.1080/07853890.2021.1925147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281072/
https://www.ncbi.nlm.nih.gov/pubmed/34259103
http://dx.doi.org/10.1080/07853890.2021.1925147

Ejemplares similares